Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia

Leukemia
M G RizzoG Blandino

Abstract

p73, the homologue of p53, is a nuclear protein whose ectopic expression, in p53+/+ and p53-/- cells, recapitulates the most well-characterized p53 effects, such as growth arrest, apoptosis and differentiation. Unlike p53, which is mutated in half of human cancers, p73 is rarely mutated. However, altered expression of the p73 gene has been reported in neuroblastoma, lung cancer, prostate cancer and renal cell carcinoma. To investigate the potential involvement of p73 in acute myeloid leukemias (AMLs), we analyzed 71 samples from AML patients for the expression pattern of N-terminal transactivation-p73alpha (TA-p73alpha), its spliced isoforms and N-terminal-deleted-p73 transcripts (DeltaN-p73). We detected p73 gene expression in AML irrespective of FAB (French-American-British) subtypes. Notably, the analysis of DeltaN-p73 expression, which has been reported to inactivate both p53 and p73 antitumor effects, revealed a rather peculiar pattern. In fact, DeltaN-p73 transcript and protein were detectable in 27/28 (96.4%) cases of M0, M1, M2, M4, M5 and M6 AML and in 13/41 (31.7%) cases of PML-RARalpha-positive M3 AML (P<0.01). Thus, the distinct gene expression profile of p73 further supports the notion that acute promyelocytic leuk...Continue Reading

References

Aug 1, 1994·American Journal of Hematology·D TreccaA Neri
Nov 1, 1993·Leukemia & Lymphoma·L LongoA Neri
Jul 31, 1998·American Journal of Human Genetics·M HodgesP S Freemont
Nov 6, 1998·The Journal of Experimental Medicine·V De LaurenziG Melino
Jan 16, 1999·Molecular and Cellular Biology·C J Di ComoC Prives
Jan 5, 2000·Oncogene·W G Kaelin
Jan 19, 2000·Cell Death and Differentiation·C H Arrowsmith
May 16, 2000·The Journal of Biological Chemistry·V De LaurenziG Melino
Jul 8, 2000·The Journal of Biological Chemistry·S StranoG Blandino
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·X T KongA T Look
Oct 12, 2000·Biochemical and Biophysical Research Communications·M P TschanJ F Cajot
Mar 30, 2001·The Journal of Biological Chemistry·S StranoG Blandino
Dec 26, 2001·Cell Death and Differentiation·T J GrobA Tobler
Jan 25, 2002·Blood·Martin S TallmanJacob M Rowe
Feb 23, 2002·Cell Death and Differentiation·T Stiewe, B M Pützer
Mar 15, 2002·The Journal of Biological Chemistry·Sabrina StranoGiovanni Blandino
Sep 6, 2002·The Journal of Biological Chemistry·Giulia FontemaggiGiovanni Blandino
Sep 18, 2002·The Journal of Experimental Medicine·Alex I ZaikaUte M Moll
Jun 6, 2003·Current Opinion in Cell Biology·Monica GostissaGiannino Del Sal
Mar 3, 2004·Molecular Cell·Elisa de StanchinaScott W Lowe

❮ Previous
Next ❯

Citations

Apr 18, 2013·Cancer Metastasis Reviews·Stella LogothetiVassilis Zoumpourlis
Mar 17, 2006·Leukemia·A PlutaP Smolewski
Apr 14, 2012·Leukemia & Lymphoma·Evguenia M Alexandrova, Ute M Moll
Feb 28, 2008·Biochimica Et Biophysica Acta·Sven Buhlmann, Brigitte M Pützer
Aug 6, 2013·Genes, Chromosomes & Cancer·Beatriz SoldevillaGemma Domínguez
Jul 6, 2012·Bioscience Reports·Dulcie LaiXiaolong Yang
May 28, 2013·Cell Cycle·Cuixia DiZhongtian Bai
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cecilia BozzettiAndrea Ardizzoni
Dec 13, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·N RodríguezG Domínguez
Mar 6, 2007·Oncogene·M P Deyoung, L W Ellisen
Aug 11, 2007·Cell Death and Differentiation·S MainardiM G Rizzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.